| Literature DB >> 32539546 |
Amr Essa1, Omar Kousa1, Dana Awad1, Makenzi Stevenson1, Bradley DeVrieze1, Douglas Moore1.
Abstract
Critically ill patients are known to have a variety of electrolyte abnormalities. Lactic acidosis can frequently be seen secondary to shock states and is usually treated with aggressive volume resuscitation. Interestingly, hypophosphatemia is a potential cause of resistant lactic acidosis, which may not be as commonly identified or considered. We present a case of a 42-year-old man admitted twice over a span of 6 months with an elevated lactate level that did not resolve with volume resuscitation. It was ultimately determined that his lactic acidosis was due to hypophosphatemia after ruling out other potential causes. Phosphate replacement therapy resulted in the normalization of his lactate. In the literature, multiple theories have indicated the association of hypophosphatemia with lactic acidosis though no prior cases exist supporting a direct relationship. In this case, we set forth to evaluate the complicated relationship between all of these factors and to highlight the importance of early detection and treatment of hypophosphatemia, which may be beneficial in treating lactic acidosis.Entities:
Keywords: case report; critical illness; hypophosphatemia; lactic acidosis; phosphorus
Mesh:
Substances:
Year: 2020 PMID: 32539546 PMCID: PMC7298210 DOI: 10.1177/2324709620934963
Source DB: PubMed Journal: J Investig Med High Impact Case Rep ISSN: 2324-7096
Laboratory Results on Presentation on the First Admission.
| Tests | Laboratory values |
|---|---|
| White blood cell (4000-12 000/µL) | 4.4 |
| Hemoglobin (12-16 g/dL) | 12.6 |
| Hematocrit (36% to 48%) | 37.4 |
| Platelet (140 000-440 000/µL) | 34 |
| Glucose (74-106 g/dL) | 50 |
| Sodium (137-145 mmol/L) | 139 |
| Potassium (3.5-5.1 mmol/L) | 3.7 |
| Chloride (98-107 mmol/L) | 100 |
| Carbon dioxide (22-30 mmol/L) | 8 |
| Urea (9-20 mg/dL) | 5 |
| Creatinine (0.7-1.2 g/dL) | 0.67 |
| Total protein (6.3-8.2 g/dL) | 8.1 |
| Albumin (3.5-5.0 g/dL) | 3.3 |
| Calcium (8.4-10.2 mg/dL) | 8.6 |
| Total bilirubin (0.2-1.3 mg/dL) | 3 |
| Aspartate aminotransferase (15-46 IU/L) | 243 |
| Alanine transaminase (4-50 IU/L) | 46 |
| Alkaline phosphates (38-126 IU/L) | 308 |
| Creatine kinase total (55-170 IU/L) | 27 |
| Lipase (73-393 U/L) | 35 |
| Brain natriuretic peptide (<124 pg/mL) | 144 |
| Troponin (<0.04) | <0.04 |
| International normalized ratio (0.9-1.1) | 1.0 |
| Magnesium (1.8-2.6 mg/dL) | 1.4 |
| Phosphate (2.5-4.5 mg/dL) | 2.1 |
| Lactate (0.5-1.0 mmol/L) | 9.8 |
| β-Hydroxybutyric acid (0.2-2.8 mg/dL) | 53.9 |
| Procalcitonin (<0.05 ng/mL) | 0.07 |
| Ethanol level (<10 mg/dL) | 90 |
| Venous pH (7.33-7.43) | 7.27 |
Laboratory Results on Presentation on the Second Admission.
| Tests | Laboratory values |
|---|---|
| White blood cell (4000-12 000/µL) | 11.6 |
| Hemoglobin (12-16 g/dL) | 12.9 |
| Hematocrit (36% to 48%) | 40.6 |
| Platelet (140 000-440 000/µL) | 61 |
| Glucose (74-106 g/dL) | 177 |
| Sodium (137-145 mmol/L) | 145 |
| Potassium (3.5-5.1 mmol/L) | 4.1 |
| Chloride (98-107 mmol/L) | 103 |
| Carbon dioxide (22-30 mmol/L) | <5 |
| Urea (9-20 mg/dL) | 15 |
| Creatinine (0.7-1.2 g/dL) | 1.24 |
| Total protein (6.3-8.2 g/dL) | 8.4 |
| Albumin (3.5-5.0 g/dL) | 3.6 |
| Calcium (8.4-10.2 mg/dL) | 8.5 |
| Total bilirubin (0.2-1.3 mg/dL) | 1.5 |
| Aspartate aminotransferase (15-46 IU/L) | 147 |
| Alanine transaminase (4-50 IU/L) | 57 |
| Alkaline phosphates (38-126 IU/L) | 189 |
| Creatine kinase total (55-170 IU/L) | 131 |
| Lipase (73-393 U/L) | 24 |
| Brain natriuretic peptide (<124 pg/mL) | 166 |
| Troponin (<0.04) | <0.04 |
| International normalized ratio (0.9-1.1) | 1.1 |
| Magnesium (1.8-2.6 mg/dL) | 2.0 |
| Phosphate (2.5-4.5 mg/dL) | 6.5 |
| Lactate (0.5-1.0 mmol/L) | 21.1 |
| β-Hydroxybutyric acid (0.2-2.8 mg/dL) | 33.6 |
| Procalcitonin (<0.05 ng/mL) | 0.18 |
| Ethanol level (<10 mg/dL) | 72 |
| Venous pH (7.33-7.43) | 6.96 |
Figure 1.Lactate and phosphate trending throughout the first admission (K, potassium; Phos, phosphate; D5%, dextrose 5%; LR, lactate Ringer’s; Na, sodium).
Figure 2.Lactate and phosphate trending throughout the second admission (K, potassium; Phos, phosphate; D5%, dextrose 5%; LR, lactate Ringer’s; Na, sodium; HCO3, bicarbonate; D5W, dextrose 5% in water).
Electrolytes Trend Throughout the First Admission Along With Total Electrolytes Replacement Therapy Administered in a 24-Hour Period.
| Hours since admission | |||||
|---|---|---|---|---|---|
| 0 | 24 | 48 | 72 | 96 | |
| Phosphate (2.5-4.9 mg/dL) | 2.1 | 1.1 | 2.9 | 2.5 | 4.2 |
| Potassium (3.7-5.1 mmol/L) | 3.7 | 2.9 | 3.5 | 4.2 | 4.0 |
| Magnesium (1.8-2.6 mg/dL) | 1.4 | 2.2 | 1.8 | 1.9 | 1.6 |
| Electrolyte replacement | 3000 mg K-Phos | 3000 mg K-Phos | 80 mEq KCl | 1000 mg K-Phos | 1000 mg K-Phos |
| 60 mEq KCl | 40 mmol K-Phos | 4 g Mag-sulfate | 2 g Mag-sulfate | ||
| 2 g Mag-sulfate | 120 mEq KCl | 400 mg Mag-Ox | |||
| 2 g Mag-sulfate | |||||
Abbreviations: K, potassium; Phos, phosphate; Mag, magnesium; Ox, oxide; Na sodium.
Electrolytes Trend Throughout the Second Admission Along With Total Electrolytes Replacement Therapy Administered in a 24-Hour Period.
| Hours since admission | |||||
|---|---|---|---|---|---|
| 0 | 24 | 48 | 72 | 96 | |
| Phosphate (2.5-4.9 mg/dL) | 6.5 | 1.1 | 2.2 | 3.2 | 3.4 |
| Potassium (3.7-5.1 mmol/L) | 5.1 | 4.8 | 3.1 | 3.4 | 3.7 |
| Magnesium (1.8-2.6 mg/dL) | 2.0 | 1.8 | 2.0 | 1.8 | 1.5 |
| Electrolyte replacement | 30 mmol K-Phos | 80 mEq KCl | 40 mEq KCl | 1000 mg K-Phos | |
| 5 g Mag-sulfate | 40 mmol K-Phos | 2 g Mag-Sulfate | |||
Abbreviations: K, potassium; Phos, phosphate; Mag, magnesium; Ox, oxide; Na, sodium.
Figure 3.General scheme of causes of lactic acidosis.
Figure 4.Mechanisms of lactic acidosis in hypophosphatemia and chronic alcoholism.